REGENXBIO, Inc. (RGNX)
11.16
-0.44
(-3.79%)
USD |
NASDAQ |
Jan 30, 16:00
11.10
-0.06
(-0.54%)
After-Hours: 20:00
REGENXBIO Total Liabilities (Quarterly) : 363.75M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Omeros Corp. | 406.18M |
| Sarepta Therapeutics, Inc. | 2.173B |
| AbbVie, Inc. | 136.50B |
| CytomX Therapeutics, Inc. | 50.86M |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 525.20M |
| Shareholders Equity (Quarterly) | 161.45M |
| Debt to Equity Ratio | 1.661 |
| Current Ratio | 2.665 |
| Net Debt Paydown Yield | -4.48% |